-
-
-
-
-
-
-
Aptorum Group shareholders approve merger with DiamiR Biosciences
-
-
-
-
-
-
-
DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2025 Conference
-
-
-
-
-
-
-
Aptorum Group regains compliance with NASDAQ minimum bid price rule
-
-
-
-
-
-
-
Aptorum Group (APM) Enters Agreement and Plan of Merger with YOOV Group and Split-off Agreement to Separate its Legacy Business
-
-
-
-
-
-
-
Aptorum Group Announces Closing of $10 Million Registered Direct Offering of Class A Ordinary Shares and Warrants
-
-
-
1,172,575 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

